Remove 2010 Remove Digital Health Remove Life Science Remove Pharmaceuticals
article thumbnail

The Committee to Restore Nymox Shareholder Value Sends Letter to Nymox Pharmaceutical Shareholders and Issues Proxy Materials for Upcoming Special Meeting

Digital Health Global

CRNSV”) was formed by former executives and directors of Nymox Pharmaceutical Corporation (“Nymox” or the “Company”), who were improperly removed from their positions, with a goal to recover shareholder value in Nymox. From 2008 until 2010, Mr. Cutler was President and Chief Executive Officer of Sustainable Power Corp.,

article thumbnail

Medicine 2.0 : Implications of Connected Medical Devices & Digital Healthcare

Lloyd Price

In October 2010, the US Federal Communications Commission and the US Food and Drug Administration (FDA) partnered to encourage investment in wireless healthcare devices, and the European authorities have become increasingly willing to give such solutions the CE marking required on drug products to be sold in Europe. Source : [link]